Cayenne Pepper (Capsaicin)

What it does

Cayenne pepper's active compounds are capsaicinoids, chiefly capsaicin, the molecule that makes chili peppers hot. Capsaicin activates and then desensitizes TRPV1 pain fibers, which is why it appears both as a kitchen spice and, at pharmaceutical strength, as a nerve-pain treatment. Cayenne is promoted heavily in natural-health teaching for circulation and heart health, including by Barbara O'Neill, whose audience brought this record into the queue.

What the research says

• Topical capsaicin relieves some chronic nerve pain, best in its high-dose medical form

  Evidence: moderate. Cochrane reviews find the clinic-applied 8 percent capsaicin patch helps a subset of patients with postherpetic and diabetic nerve pain (numbers needed to treat around 9 to 12 for meaningful relief, lasting up to three months per application); it is an FDA-approved product (Qutenza). Low-strength creams (0.075 percent) show an NNT of about 6.6 for any relief in older pooling, but capsaicin burns, which breaks blinding in every cream trial, and later Cochrane assessments are more skeptical of the low-dose form.

• Oral capsaicinoids slightly reduce how much people eat at a meal

  Evidence: weak. Whiting's meta-analysis (10 trials, 191 participants): capsaicinoids before a meal reduced intake by about 74 kcal at that meal, with high heterogeneity (I-squared 76 percent), and energy expenditure rose by roughly 50 kcal/day in related analyses. Acute appetite effects in tiny short studies; no trial connects them to actual weight loss.

• The popular claim that cayenne stops a heart attack has no human evidence behind it

  Evidence: weak. This claim circulates widely in natural-health media. No study shows cayenne or capsaicin halting a heart attack, and no cohort association between eating chili and lower mortality (such associations exist, and are confounded) can support a rescue claim. Its risk is the delay it can cause: chest pain is an emergency call, not a spice decision. Graded here under the gap rule because the claim's popularity is the reason many readers arrive.

One ingredient, three claims, three different evidence worlds. The topical derivative is a legitimate, regulatory-approved nerve-pain treatment with modest average effects and honest Cochrane scrutiny. The oral metabolic effect is real, acute, and too small and short-studied to grade as a weight tool. The cardiovascular fame rests on cohort associations for eating chili and a rescue claim with no human evidence at all. Averaged into one grade for the supplement as sold, that is a C: a real drug-grade use sits inside this record, and it is not the use on the capsule label.

Is it worth it?

Evidence (C) sits below the leaderboard floor, so the worth-it grade is capped at C+ however inexpensive it is; the derived value lands at C. About $9 a month for the supplement form. Derived from the October 2026 worth-it model.